[1]
|
Bay-Jensen A.C., Hoegh-Madsen S., Dam E., Henriksen K., Sondergaard B.C., Pastoureau P., Qvist P., Karsdal M.A. (2010) Which elements are involved in reversible and irreversible cartilage damage in osteoarthritis. Rheumatol. Int., 30: 435-42.
|
[2]
|
Miller M.J.S., Akhtar N., Haqqi T.M. Effect of a herbal-leucine mix on the IL-1β-induced cartilage degradation and inflammatory gene expression in human chondrocytes. (2011) BMC Complementary and Alternative Medicine, 11:66
|
[3]
|
Chopra A. (2004) Rheumatology: made in India (Camps, COPCORD, HLA, Ayurveda, HAQ, WOMAC and Drug Trials). J Indian Rheumatol Assoc., 12: 43-53.
|
[4]
|
Clegg D.O. et al., (2006) Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med., 354: 795-808.
|
[5]
|
Bjarnason I., Thjodleifsson B. (1999) Gastrointestinal toxicity of non-steroidal anti-inflammatory drugs: the effect of nimesulide compared with naproxen on the human gastrointestinal tract. Rheumatology, 38: 24-32.
|
[6]
|
Biggee B.A., Blinn C.H., Nuity M., Silbert J.E., McAlindon T.E. (2007) Effects of oral glucosamine sulfate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis. Ann Rheum. Dis., 66, 260-262.
|
[7]
|
Pham T., Cornea A., Blick K.E., Jenkins A., Scofield R.H. (2007) Oral glucosamine in doses used to treat osteoarthritis worsens insulin resistance. Ann J. Med. Sci., 333: 333-339.
|
[8]
|
Roman-Blas J.A., Jimenez S.A. (2006) NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage.,14: 839-48.
|
[9]
|
Kimmatkar N., Thawani V., Hingorani L., Khiyani R. (2003) Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee-a randomized double blind placebo controlled trial. Phytomedicine, 10:3-7
|
[10]
|
Sontakke S., Thawani V., Pimpalkhute S., Kabra P., Babhulkar S., Hingorani L. (2007). Open, randomized, controlled clinical trial of Boswellia serrata extract as compared to valdecoxib in osteoarthritis of knee. Indian J. Pharmacol., 39: 27 – 29.
|
[11]
|
Sandoval-Chacon M., Thompson J.H., Liu X., Mannick E.E., Sadowska-Krowicka H., Charbonnet R., Clark D.A., Miller M.J.S. (1998) Anti-inflammatory actions of cat's claw: the role of NF-B. Alimentary Pharmacol. Therap., 12: 1279-1289.
|
[12]
|
Sandoval M., Charbonnet R.M., Okuhama N.N., Roberts J., Krenova Z., Trentacosti A.M., Miller M.J.S. (2000) Cat’s claw inhibits TNF production and scavenges free radicals: role in cytoprotection. Free Radical Biol. Med., 29: 71-78.
|
[13]
|
Piscoya J., Rodriguez Z., Bustamante S., Miller M.J.S., Sandoval M. (2001) Efficacy and safety of freeze dried cat’s claw in osteoarthritis of the knee: mechanisms of action of the specie Uncaria guianensis. Inflammation Research, 50: 442-448.
|
[14]
|
Miller M.J., Ahmed S., Bobrowski P., Haqqi T.M. (2006) The chrondroprotective actions of a natural product are associated with the activation of IGF-1 production by human chondrocytes despite the presence of IL-1beta. BMC Complement Altern. Med., 6:13
|
[15]
|
Crowe M.J., Weatherson J.N., Bowden B.F. (2006) Effects of dietary leucine supplementation on exercise performance. Eur J Appl Physiol., 97(6): 664-72.
|
[16]
|
Li F., Yin Y., Tan B., Kong X., Wu G. (2001) Leucine nutrition in animals and humans: mTOR signaling and beyond. Amino Acids, 41:1185-93.
|
[17]
|
Adams S.B. Jr., Setton L.A., Kensicki E., Bolognesi M.P., Toth, A.P., Nettles, D.L. (2012) Global metabolic profiling of human osteoarthritic synovium. Osteoarthritis and Cartilage, 20, 64-67.
|
[18]
|
Zhang W., Robertson J., Jones A.C., Dieppe P.A., Doherty M. A. (2008) Placebo effect and its determinants in osteoarthritis: meta-analysis of randomized controlled trials. Ann Rheum. Dis., 67: 1716-1723.
|